SCHEMBL6672234

SCHEMBL6672234

CN(Cc1ccc(Cl)cc1)C(=O)c1n[nH]c2c(CCCCO)cc(CC3CCOCC3)cc2c1=O

nearest known ligand 0.34

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
NR1H4 Q96RI1 1/20 0.34
MAPK14 Q16539 1/20 0.32
GSK3B P49841 2/20 0.32
KCNH2 Q12809 2/20 0.32
HSP90AA1 P07900 1/20 0.32
P2RX7 Q99572 3/20 0.31
CSF1R P07333 1/20 0.31
NAPEPLD Q6IQ20 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30
NPC1 O15118 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6667531 0.98 NR1H4 (0.34) NR1H4MAPK14GSK3BKCNH2HSP90AA1
SCHEMBL7482403 0.92 NR1H4 (0.34) NR1H4MAPK14GSK3BKCNH2HSP90AA1
SCHEMBL6666111 0.89 NR1H4 (0.37) NR1H4HSP90AA1P2RX7SMN1; SMN2NPC1
SCHEMBL6672672 0.84 NR1H4 (0.34) NR1H4MAPK14GSK3BKCNH2HSP90AA1
SCHEMBL6671253 0.84 NR1H4 (0.32) NR1H4SMN1; SMN2
SCHEMBL6672237 0.84 NR1H4 (0.33) NR1H4MAPK14GSK3BKCNH2HSP90AA1
SCHEMBL6668749 0.81 NR1H4 (0.36) NR1H4GSK3BKCNH2HSP90AA1P2RX7
SCHEMBL6672671 0.80 NR1H4 (0.40) NR1H4MAPK14HSP90AA1SMN1; SMN2NPC1
SCHEMBL7477339 0.78 NR1H4 (0.35) NR1H4HSP90AA1P2RX7NPC1
SCHEMBL6670849 0.77 NR1H4 (0.41) NR1H4MAPK14HSP90AA1SMN1; SMN2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004019940-A1 METHOD OF PREVENTING OR TREATING ATHEROSCLEROSIS OR RESTENOSIS PHARMACIA & UPJOHN COMPANY (US) 2004-03-11 WO claimed
WO-2004019940-A1 METHOD OF PREVENTING OR TREATING ATHEROSCLEROSIS OR RESTENOSIS PHARMACIA & UPJOHN COMPANY (US) 2004-03-11 WO disclosed